Ani pharma announces fda approval of memantine hydrochloride extended-release capsules

Ani pharmaceuticals announces fda approval of memantine hydrochloride extended-release capsules.ani pharma- got approval of anda rom u.s. fda for memantine hydrochloride extended-release capsules 7 mg, 14 mg, 21 mg and 28 mg.
ANIP Ratings Summary
ANIP Quant Ranking